oncotypedx.comMaking cancer care smarter with Oncotype DX tests | Oncotype IQ®

× Title Description × × × Toggle navigation  United States Brazil Canada - English Canada - Français Deutschland France Ελλάδα Ireland Latin America Spain United Kingdom 日本 See All Physician Login Healthcare Professionals Patients & Caregivers About Oncotype IQ  Contact Us Tissue-Based Assays Oncotype DX Breast DCIS Score About the test Clinical evidence How does it compare to other genomic tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Available Now For a refined risk estimate of local recurrence Learn More Learn More Oncotype DX Breast Recurrence Score About the test Clinical evidence How does it compare to other genomic tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Prospective Outcomes: TAILORx Primary study group results were presented at ASCO 2018. Read Full Text Read Full Text Oncotype DX Genomic Prostate Score About Oncotype DX GPS The genomic approach Evidence GPS works How does it compare to other tests? Is your patient eligible? Insurance coverage & financial assistance Order the test Interpreting GPS results How to talk to your patient about Oncotype DX GPS Publications Clinical Utility: Active Surveillance In a large clinical data set GPS increased AS utilzation Read Full Text Read Full Text Oncotype DX Colon Recurrence Score About the test Evidence it works How does it compare to other tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Genomics Infographic Help Stage II colon cancer patients understand the power of genomics Download Download Liquid-Based Assays Oncotype DX AR-V7 Nucleus Detect About the test Why nuclear detection Clinical evidence Is your patient eligible Insurance coverage and financial assistance How to order the test Interpreting the results Perspectives in mCRPC Publications Clinical Comparator Trial Nuclear-specific vs. nuclear-agnostic AR-V7 testing Read Full Text Read Full Text Introducing Our Newest Test Learn More Learn More Breast Cancer Stage 0 - DCIS About the test Eligibility and testing Insurance coverage & financial assistance Oncotype DX Results: What to expect Hear from our patients FAQs and useful videos Do You Really Need Radiation Therapy? Your Oncotype DX score can help you decide. Stage I-IIIA - Invasive About the test Eligibility and testing Insurance coverage & financial assistance Oncotype DX Results: What to expect Hear from our patients FAQs and useful videos Do You Really Need Chemotherapy? Oncotype DX has helped thousands of women find out. Colon Cancer Stage II-IIIB About the test Eligibility and testing Insurance coverage and financial assistance Oncotype DX Results: What to expect FAQs Real Patients. Real Stories. When Dan's Colon Recurrence Score came back low, he decided against chemotherapy. Prostate Cancer Early Stage Why Oncotype DX GPS? Clinical eligibility and testing Insurance coverage & financial assistance Oncotype DX GPS Results: Interpreting the results Hear from our patients FAQs and useful videos News Coverage Read what the Wall Street Journal is saying about the Oncotype DX Genomic Prostate Score test. Read the Article Read the Article Metastatic About the test Eligibility & testing Insurance coverage & financial assistance AR-V7 Nucleus Detect results: What to expect FAQs Get Our Patient Brochure Download Download Our Award-Winning App Helps You Stay Organized Get Free App Get Free App Home Healthcare Professionals Healthcare Professionals Breast Cancer Oncotype DX Breast DCIS Score Oncotype DX Breast DCIS Score About the test Clinical evidence How does it compare to other genomic tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Oncotype DX Breast Recurrence Score Oncotype DX Breast Recurrence Score About the test Clinical evidence How does it compare to other genomic tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Prostate Cancer Oncotype DX Genomic Prostate Score Oncotype DX Genomic Prostate Score About Oncotype DX GPS The genomic approach Evidence GPS works How does it compare to other tests? Is your patient eligible? Insurance coverage & financial assistance Order the test Interpreting GPS results How to talk to your patient about Oncotype DX GPS Publications Oncotype DX AR-V7 Nucleus Detect Oncotype DX AR-V7 Nucleus Detect About the test Why nuclear detection Clinical evidence Is your patient eligible Insurance coverage and financial assistance How to order the test Interpreting the results Perspectives in mCRPC Publications Colon Cancer Oncotype DX Colon Recurrence Score Oncotype DX Colon Recurrence Score About the test Evidence it works How does it compare to other tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Patients & Caregivers Patients & Caregivers Breast Cancer Stage 0 - DCIS Stage 0 - DCIS About the test Eligibility and testing Insurance coverage & financial assistance Oncotype DX Results: What to expect Hear from our patients FAQs and useful videos Stage I-IIIA - Invasive Stage I-IIIA - Invasive About the test Eligibility and testing Insurance coverage & financial assistance Oncotype DX Results: What to expect Hear from our patients FAQs and useful videos Prostate Cancer Early Stage Early Stage Why Oncotype DX GPS? Clinical eligibility and testing Insurance coverage & financial assistance Oncotype DX GPS Results: Interpreting the results Hear from our patients FAQs and useful videos Metastatic Metastatic About the test Eligibility & testing Insurance coverage & financial assistance AR-V7 Nucleus Detect results: What to expect FAQs Colon Cancer Stage II-IIIB Stage II-IIIB About the test Eligibility and testing Insurance coverage and financial assistance Oncotype DX Results: What to expect FAQs About Oncotype IQ Contact Us Resources Resources Videos Brochures Online Ordering Sign-up United States Brazil Canada - English Canada - Français Deutschland France Ελλάδα Ireland Latin America Spain United Kingdom 日本 See All Physician Login Smarter Cancer Care In collaboration with thousands of physicians around the world, over one million patients improved their outcomes with the Oncotype IQ portfolio of genomic tests. -- In collaboration with thousands of physicians around the world, over one million patients improved their outcomes with the Oncotype IQ portfolio of genomic tests. Learn More The only genomic test proven to predict a patient’s individual benefit from chemotherapy. For patients with early-stage, ER-positive, HER2-negative, node negative, and node-positive (1-3) breast cancer, the Oncotype DX Breast Recurrence Score quantifies the risk of distant recurrence and the likelihood of chemotherapy benefit. About the Test READ MORE The only genomic test to quantify the risk of local recurrence (DCIS or invasive) in ductal carcinoma in situ. For patients with ductal carcinoma in situ (DCIS) treated by local excision, with or without tamoxifen, the Oncotype DX Breast DCIS Score can help guide personalized treatment decisions. About the Test READ MORE Decide whether immediate treatment is necessary or confidently opt for active surveillance. For patients with clinically low-risk prostate cancer (very low, low, or intermediate NCCN risk) the Oncotype DX Genomic Prostate Score predicts the likelihood of favorable pathology (low-grade [3+3, 3+4], organ-confined disease). About the Test READ MORE The first and only test to identify patients who will not respond to AR-targeted therapies For patients with ...